NCT05410873View on ClinicalTrials.gov

Examining the Effects of Mitochondrial Oxidative Stress in DCM

PHASE2CompletedINTERVENTIONAL

Enrollment

53

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

June 19, 2024

Study Completion Date

June 19, 2024

Conditions

Dilated Cardiomyopathy

Interventions

DRUG

MitoQ Compound

Mitoquinol mesylate

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Royal Brompton Hospital, London

All Listed Sponsors

collaborator

British Heart Foundation

OTHER

lead

Imperial College London

OTHER